The OviTex PRS portfolio now includes a larger option than any human acellular dermal matrix product on the marketMALVERN, Pa., March 31, 2025 (GLOBE NEWSWIRE) -- TELA Bio, Inc. (NASDAQ: TELA), a ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback